PELVIC RECURRENCE following curative surgery for rectal cancer is common, ranging between 5% and 45%.
1-4 This considerable variation in different series is probably due to differing quality of surgical treatment.
3,4 It is increasingly believed that many of these local recurrences are due to incomplete excision of metastatic deposits scattered in the supporting structures around the rectum.
1,3,5,6 Most frequently, local cancer spread discontinuous with the primary rectal tumor takes place in the mesorectal lymph nodes (nodal metastases [NM]). However, nonnodal metastases (NNM), which have been described in other organs,
7 have been found within the mesorectum and outside it along lateral pelvic vessels, autonomic nerves, and the pelvic wall.
1,2,5,7-9 Our aim was to determine the incidence of NM and NNM, their relation to other clinicopathologic characteristics, and their influence on survival and recurrence rate in patients treated with curative low anterior resection (LAR).